Alacizumab (Anti-VEGFR2 / KDR / CD309), 1mg*25

Alacizumab (Anti-VEGFR2 / KDR / CD309), 1mg*25

Vulinacimab (Anti-VEGFR2 / KDR / CD309), 1mg*5

Vulinacimab (Anti-VEGFR2 / KDR / CD309), 1mg*5

Vulinacimab (Anti-VEGFR2 / KDR / CD309), 1mg

3.700,90 RON
SKU
SKM_A3110_1mg

Vulinacimab (Anti-VEGFR2 / KDR / CD309) is a monoclonal antibody targeting VEGFR-2. It has potential anti-angiogenesis and antineoplastic activities and can be used in the research of cancers. MW :145.38 KD.

Mai multe informatii
Price 3.110,00 RON (preturile sunt fara TVA)
Description

Vulinacimab (Anti-VEGFR2 / KDR / CD309) is a monoclonal antibody targeting VEGFR-2. It has potential anti-angiogenesis and antineoplastic activities and can be used in the research of cancers. MW :145.38 KD.